Joshua Gardner

7PUBLICATIONS
21CO-AUTHORS
Innate immunityMolecular medicineMedical infection agents (incl. prions)Predictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 06, 2026
Immune checkpoint inhibition enhances memory T-cell responses to CEF(T), SARS-CoV-2 spike proteins and ChAdOx1 nCoV-19.

|Jun 21, 2025
TSC22 domain family member 3 links natural killer cells to CD8+ T cell-mediated drug hypersensitivity.

Lele Sun, Pengcheng Huai, Zhenzhen Wang

|May 27, 2025
Elucidating CD4+ and CD8+ T-cell involvement in patients with vancomycin-induced DRESS.

Joshua Gardner, Silvia Martinez-Rivera, James Line

|Jun 05, 2024
Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines.

Joshua Gardner, Simon Timothy Abrams, Cheng-Hock Toh

|Jan 04, 2024
Glycolysis: An early marker for vancomycin-specific T-cell activation.

Joshua Gardner, Sean Hammond, Rebecca Jensen

|Mar 07, 2023
Activation of Human CD8+ T Cells with Nitroso Dapsone-Modified HLA-B*13:01-Binding Peptides.

Mubarak Almutairi, Adam Lister, Qing Zhao

Pageof 2

Frequent Collaborators

2 joint publications

Paul Thomson

2 joint publications

Xiaoli Meng

2 joint publications

Dean J Naisbitt

1 joint publications

Adam Lister